HRP20100680T1 - Upotreba agomelatina za dobivanje lijeka u cilju lijecenja periventrikularne leukomalacije - Google Patents

Upotreba agomelatina za dobivanje lijeka u cilju lijecenja periventrikularne leukomalacije Download PDF

Info

Publication number
HRP20100680T1
HRP20100680T1 HR20100680T HRP20100680T HRP20100680T1 HR P20100680 T1 HRP20100680 T1 HR P20100680T1 HR 20100680 T HR20100680 T HR 20100680T HR P20100680 T HRP20100680 T HR P20100680T HR P20100680 T1 HRP20100680 T1 HR P20100680T1
Authority
HR
Croatia
Prior art keywords
agomelatine
periventricular leukomalacia
pharmaceutically acceptable
treatment
indicated
Prior art date
Application number
HR20100680T
Other languages
English (en)
Croatian (hr)
Inventor
Spedding Michael
Mocaer Elisabeth
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38229589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100680(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20100680T1 publication Critical patent/HRP20100680T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20100680T 2006-11-24 2010-12-07 Upotreba agomelatina za dobivanje lijeka u cilju lijecenja periventrikularne leukomalacije HRP20100680T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610294A FR2908994B1 (fr) 2006-11-24 2006-11-24 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement de la leucomalacie periventriculaire

Publications (1)

Publication Number Publication Date
HRP20100680T1 true HRP20100680T1 (hr) 2011-01-31

Family

ID=38229589

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100680T HRP20100680T1 (hr) 2006-11-24 2010-12-07 Upotreba agomelatina za dobivanje lijeka u cilju lijecenja periventrikularne leukomalacije

Country Status (37)

Country Link
US (1) US20080125493A1 (de)
EP (1) EP1927351B1 (de)
JP (1) JP4870062B2 (de)
KR (1) KR100976000B1 (de)
CN (1) CN101185644B (de)
AR (1) AR063895A1 (de)
AT (1) ATE483458T1 (de)
AU (1) AU2007234600B2 (de)
BR (1) BRPI0704179A (de)
CA (1) CA2610637C (de)
CL (1) CL2007003395A1 (de)
CY (1) CY1110875T1 (de)
DE (1) DE602007009627D1 (de)
DK (1) DK1927351T3 (de)
EA (1) EA014067B1 (de)
ES (1) ES2353128T3 (de)
FR (1) FR2908994B1 (de)
GE (1) GEP20094747B (de)
HR (1) HRP20100680T1 (de)
JO (1) JO2631B1 (de)
MA (1) MA29522B1 (de)
ME (1) ME01866B (de)
MX (1) MX2007014004A (de)
MY (1) MY145925A (de)
NO (1) NO338598B1 (de)
NZ (1) NZ563683A (de)
PE (1) PE20081158A1 (de)
PL (1) PL1927351T3 (de)
PT (1) PT1927351E (de)
RS (1) RS51494B (de)
SG (1) SG143202A1 (de)
SI (1) SI1927351T1 (de)
TW (1) TW200829236A (de)
UA (1) UA94043C2 (de)
UY (1) UY30703A1 (de)
WO (1) WO2008071869A2 (de)
ZA (1) ZA200710102B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2645223T3 (es) 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales
EP2810647A1 (de) * 2013-06-06 2014-12-10 Zentiva, a.s. Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2003011271A2 (en) * 2001-08-03 2003-02-13 Children's Medical Center Corporation Methods and compositions for modulating brain damage
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
FR2908994B1 (fr) 2009-04-03
NZ563683A (en) 2009-04-30
RS51494B (sr) 2011-04-30
MX2007014004A (es) 2009-02-16
EP1927351A1 (de) 2008-06-04
MA29522B1 (fr) 2008-06-02
JP4870062B2 (ja) 2012-02-08
CA2610637A1 (fr) 2008-05-24
WO2008071869A2 (fr) 2008-06-19
NO20076002L (no) 2008-05-26
AR063895A1 (es) 2009-02-25
WO2008071869A3 (fr) 2008-08-14
FR2908994A1 (fr) 2008-05-30
ES2353128T3 (es) 2011-02-25
AU2007234600B2 (en) 2012-05-17
CN101185644B (zh) 2011-08-10
DE602007009627D1 (de) 2010-11-18
DK1927351T3 (da) 2011-01-10
ME01866B (me) 2011-04-30
ZA200710102B (en) 2008-11-26
PT1927351E (pt) 2010-10-27
EA200702317A1 (ru) 2008-06-30
EP1927351B1 (de) 2010-10-06
GEP20094747B (en) 2009-07-27
SI1927351T1 (sl) 2010-12-31
NO338598B1 (no) 2016-09-12
AU2007234600A1 (en) 2008-06-12
BRPI0704179A (pt) 2008-07-08
TW200829236A (en) 2008-07-16
US20080125493A1 (en) 2008-05-29
EA014067B1 (ru) 2010-08-30
CY1110875T1 (el) 2015-06-10
ATE483458T1 (de) 2010-10-15
SG143202A1 (en) 2008-06-27
PL1927351T3 (pl) 2011-01-31
PE20081158A1 (es) 2008-10-04
KR100976000B1 (ko) 2010-08-17
CL2007003395A1 (es) 2008-09-12
CN101185644A (zh) 2008-05-28
UY30703A1 (es) 2008-01-02
KR20080047298A (ko) 2008-05-28
HK1118216A1 (en) 2009-02-06
MY145925A (en) 2012-05-15
AU2007234600A8 (en) 2010-12-02
JP2008133279A (ja) 2008-06-12
UA94043C2 (ru) 2011-04-11
CA2610637C (fr) 2011-04-19
JO2631B1 (en) 2012-06-17

Similar Documents

Publication Publication Date Title
HRP20100577T1 (hr) Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti
MX2022014444A (es) Sal de malato de n-(4-{[6,7-bis(metiloxi) quinolin-4-il] oxi}fenil)-n'-(4-fluorofenil) ciclopropano-1,1-dicarboxamida, y sus formas cristalinas para el tratamiento de cancer.
JP2014530220A5 (de)
HRP20110370T1 (hr) Uporaba agomelatina za dobivanje lijeka u cilju liječenja smith-magenisovog sindroma
EA201590166A1 (ru) Комбинированная терапия для лечения рассеянного склероза
ATE539747T1 (de) Verfahren und medikamente zur verabreichung von ibuprofen
JP2013541583A5 (de)
AR056063A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento de trastornos del sueno en el paciente deprimido
HRP20120344T1 (hr) N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije
HRP20100680T1 (hr) Upotreba agomelatina za dobivanje lijeka u cilju lijecenja periventrikularne leukomalacije
NZ591328A (en) Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
HRP20110083T1 (hr) Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja
HRP20180537T1 (hr) Uporaba agomelatina za pripravu lijekova za liječenje opsesivno-kompulzivnog poremećaja (ocd)
MX2022012693A (es) Composicion que comprende metilfolato.
EA201400484A1 (ru) Трансдермальное средство для лечения и профилактики болезней суставов и мягких тканей
EA201990129A1 (ru) Таблетированный состав с улучшенным профилем растворения для лечения болезни паркинсона
RU2019102890A (ru) Фармацевтические композиции, содержащие флурбипрофен
AR081007A1 (es) Combinacion farmaceutica caracterizada porque comprende ibuprofeno y l-arginina
Timerbaev et al. Assessment of pain relief in patients receiving different variants of multimodal analgesia after major gynecological surgery
RU2015121239A (ru) Комбинированная фармацевтическая композиция для лечения болевых синдромов
FI4037685T3 (fi) Serca:a moduloiva kinoliini ja sen käyttö sairauden hoidossa
XIAOFEI Chinese Medica Market Attracts Global Players
RU2009142700A (ru) Противовоспалительное и противоаллергическое лекарственное средство и фармацевтическая композиция на его основе
NZ762140A (en) Carbamoyl phenylalaninol analogs and uses thereof
EA201000810A1 (ru) Фармацевтическая композиция